Expert insights. Personalized for you.
A merger with Foresite Capital's blank-check company makes Pardes Biosciences the latest well-funded drugmaker pursuing development of an oral coronavirus antiviral MORE
145 The German companies will work together to push a shot using similar technology as Moderna's and BioNTech's over the finish line MORE
Defying expectations, BioNTech and Moderna each designed and developed highly effective coronavirus shots far faster than previously considered possible MORE
The post Developing Drug Products with the Label’s Commercial Value in Mind appeared first on Camargo. Whether you plan to out-license or commercialize your product, getting the label right matters. MORE
The post In the News: July Regulatory and Development Updates appeared first on Camargo. 505(b)(2) Development Blog DESI Drug Regulatory Strategy & SubmissionsEach month, Camargo’s “In the News” series will highlight important changes and advancements in the. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explore how those changes could impact your program. Fitbit developing algorithm COVID-19 early detection. MORE
Care needs to be taken during analytical development to ensure methodologies firstly, reflect the MoA, and are also reproducible, accurate, and robust MORE
The post Drug Development for an Aging Population appeared first on Camargo. Fueled by unprecedented medical, technological and social advancements of the past century, it should be. Blog Combination Products MORE
Credit: Lorna Dougan/Phospho Animations Scientists at the University of Leeds have developed an approach that could help in the design of a new generation of synthetic biomaterials made from proteins. MORE
Bio DevelopmentsBiotech, Mogrify, recently closed a Series A financing of US$17m, bringing the total raised to US$33m in the round, with the investment set to support the advancement of the companyâs immuno-oncology and ophthalmology programs. MORE
56 
A deal with biotech startup Capsida, which recently raised $140 million, gives CRISPR access to a Caltech technology that aims to improve the delivery of genetic medicines MORE
The two Swiss firms will develop protein drugs that are meant to have similar effects as coronavirus antibodies, but would be easier to mass produce MORE
The offering is the latest step in the rapid emergence of Adagio, which raised nearly $400 million and brought a drug to pivotal testing in less than a year MORE
Get up to speed with the latest developments in COVID-19 vaccines here. Bio DevelopmentsTook a break over Christmas and New Year? MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: March 2021 Regulatory and Development Updates. MORE
ConserV Bioscience and eTheRNA immunotherapies are to collaborate on development of mRNA vaccines for infectious diseases. Bio Developments MORE
The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo. Blog Clinical Studies, Phases I-IV CMC Regulatory Strategy & Submissions Services MORE
130 The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo. Case Studies MORE
130 The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions. Clinical Development MORE
Camargo can help you to develop the right pricing and access strategy for your product; contact us for more information. The post In the News: November Regulatory and Development Updates appeared first on Camargo. Remote Document Review Leads to CRL: Be Careful What You Wish for? MORE
The post What to Expect from the FDA During COVID-19 Product Development appeared first on Camargo. As the COVID-19 national emergency stretches on in the United States, the eyes of the. Blog Regulatory Strategy & Submissions MORE
The post Patient-Centered Drug Development for Oncology Products appeared first on Camargo. Oncology patients face a difficult journey — a frightening diagnosis followed by intricate and oftentimes. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Camargo has extensive experience in the development and approval of drugs with a single pivotal study. MORE
This trend progressively reduces the attractiveness of engaging in the early stages of oncology therapy development in the eyes of Big Pharma and opens the space for small pharma and biotech players. Become Fluent in the Drug Development “Languages.”. MORE
Biology Biomedical/Environmental/Chemical Engineering Materials Research/Development Technology/Engineering/Computer Science MORE
Led by CEO Samantha Singer, Abata Therapeutics has $95 million to advance its plans to engineer regulatory T cells for treating autoimmune diseases MORE
A number of drugmakers have recently faced development delays after the FDA's asked for more information on how they measure the potency of their products MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: September Regulatory and Development Updates appeared first on Camargo. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: April 2021 Regulatory and Development Updates. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: March 2021 Regulatory and Development Updates. MORE
Collaboration will focus on developing small molecule medicines targeting GPR75 MORE
Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples Credit: MPI f. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Fotivda was initially developed for first-line RCC. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: October Regulatory and Development Updates appeared first on Camargo. MORE
Clinical DevelopmentAccording to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes. MORE
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance MORE
Gritstone Oncology, known for its cancer research, is drawing attention in infectious disease, signing a deal with Gilead two weeks after announcing plans to develop a coronavirus vaccine MORE
OWSD-Elsevier Foundation Awards for Early-Career Women Scientists in the Developing World award winners. We know how important recognition and professional visibility are for developing high-profile international scientific careers,” said Ylann Schemm, Director of the Elsevier Foundation. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The required reporting process is often a source of confusion for IND sponsors new to drug development. MORE
The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials MORE
BioNTech aims to develop the first mRNA-based malaria vaccine, hoping to reach clinical trials by 2022. Bio Developments MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: May 2021 Regulatory and Development Updates. MORE
Far along in testing for a hemophilia treatment, BioMarin is expanding its gene therapy research into diseases of the central nervous system and aims to use some of the institute's technology MORE
Development Related Topics 
Camargo
JULY 8, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The required reporting process is often a source of confusion for IND sponsors new to drug development.
Camargo
JUNE 4, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: May 2021 Regulatory and Development Updates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 25, 2021
The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials
Camargo
APRIL 7, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Fotivda was initially developed for first-line RCC.
Camargo
AUGUST 13, 2020
The post In the News: July Regulatory and Development Updates appeared first on Camargo. 505(b)(2) Development Blog DESI Drug Regulatory Strategy & SubmissionsEach month, Camargo’s “In the News” series will highlight important changes and advancements in the.
Bio Pharma Dive
MAY 19, 2021
A number of drugmakers have recently faced development delays after the FDA's asked for more information on how they measure the potency of their products
Bio Pharma Dive
JULY 19, 2021
The offering is the latest step in the rapid emergence of Adagio, which raised nearly $400 million and brought a drug to pivotal testing in less than a year
Camargo
SEPTEMBER 15, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explore how those changes could impact your program. Fitbit developing algorithm COVID-19 early detection.
Camargo
JULY 24, 2020
The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo. Case Studies
Scienmag
MAY 14, 2021
Biology Biomedical/Environmental/Chemical Engineering Materials Research/Development Technology/Engineering/Computer Science
Camargo
MAY 10, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: April 2021 Regulatory and Development Updates.
Camargo
MAY 19, 2020
The post What to Expect from the FDA During COVID-19 Product Development appeared first on Camargo. As the COVID-19 national emergency stretches on in the United States, the eyes of the. Blog Regulatory Strategy & Submissions
Camargo
JUNE 3, 2020
The post Patient-Centered Drug Development for Oncology Products appeared first on Camargo. Oncology patients face a difficult journey — a frightening diagnosis followed by intricate and oftentimes.
Camargo
JULY 23, 2020
The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo. Blog Clinical Studies, Phases I-IV CMC Regulatory Strategy & Submissions Services
Camargo
MARCH 9, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: March 2021 Regulatory and Development Updates.
Outsourcing Pharma
MAY 20, 2021
Clinical DevelopmentAccording to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes.
Camargo
JANUARY 14, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Camargo has extensive experience in the development and approval of drugs with a single pivotal study.
Bio Pharma Dive
JUNE 29, 2021
A merger with Foresite Capital's blank-check company makes Pardes Biosciences the latest well-funded drugmaker pursuing development of an oral coronavirus antiviral
BioPharma Reporter
JULY 27, 2021
BioNTech aims to develop the first mRNA-based malaria vaccine, hoping to reach clinical trials by 2022. Bio Developments
Bio Pharma Dive
FEBRUARY 1, 2021
Gritstone Oncology, known for its cancer research, is drawing attention in infectious disease, signing a deal with Gilead two weeks after announcing plans to develop a coronavirus vaccine
Camargo
NOVEMBER 11, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: October Regulatory and Development Updates appeared first on Camargo.
Camargo
FEBRUARY 4, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: March 2021 Regulatory and Development Updates.
Bio Pharma Dive
FEBRUARY 22, 2021
Care needs to be taken during analytical development to ensure methodologies firstly, reflect the MoA, and are also reproducible, accurate, and robust
BioPharma Reporter
MARCH 8, 2021
ConserV Bioscience and eTheRNA immunotherapies are to collaborate on development of mRNA vaccines for infectious diseases. Bio Developments
BioPharma Reporter
JANUARY 4, 2021
Get up to speed with the latest developments in COVID-19 vaccines here. Bio DevelopmentsTook a break over Christmas and New Year?
Camargo
OCTOBER 14, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: September Regulatory and Development Updates appeared first on Camargo.
Pharma R&D Today
JULY 7, 2021
OWSD-Elsevier Foundation Awards for Early-Career Women Scientists in the Developing World award winners. We know how important recognition and professional visibility are for developing high-profile international scientific careers,” said Ylann Schemm, Director of the Elsevier Foundation.
Camargo
DECEMBER 9, 2020
Camargo can help you to develop the right pricing and access strategy for your product; contact us for more information. The post In the News: November Regulatory and Development Updates appeared first on Camargo. Remote Document Review Leads to CRL: Be Careful What You Wish for?
Bio Pharma Dive
OCTOBER 28, 2020
The two Swiss firms will develop protein drugs that are meant to have similar effects as coronavirus antibodies, but would be easier to mass produce
Camargo
APRIL 20, 2021
This trend progressively reduces the attractiveness of engaging in the early stages of oncology therapy development in the eyes of Big Pharma and opens the space for small pharma and biotech players. Become Fluent in the Drug Development “Languages.”.
Pharma Times
JULY 28, 2021
Collaboration will focus on developing small molecule medicines targeting GPR75
Bio Pharma Dive
JUNE 23, 2021
Led by CEO Samantha Singer, Abata Therapeutics has $95 million to advance its plans to engineer regulatory T cells for treating autoimmune diseases
BioPharma Reporter
JULY 1, 2021
Bio DevelopmentsBiotech, Mogrify, recently closed a Series A financing of US$17m, bringing the total raised to US$33m in the round, with the investment set to support the advancement of the companyâs immuno-oncology and ophthalmology programs.
Camargo
DECEMBER 31, 2019
The post Drug Development for an Aging Population appeared first on Camargo. Fueled by unprecedented medical, technological and social advancements of the past century, it should be. Blog Combination Products
Bio Pharma Dive
JUNE 15, 2021
A deal with biotech startup Capsida, which recently raised $140 million, gives CRISPR access to a Caltech technology that aims to improve the delivery of genetic medicines
Scienmag
JULY 6, 2021
Credit: Lorna Dougan/Phospho Animations Scientists at the University of Leeds have developed an approach that could help in the design of a new generation of synthetic biomaterials made from proteins.
Bio Pharma Dive
JANUARY 7, 2021
The German companies will work together to push a shot using similar technology as Moderna's and BioNTech's over the finish line
Camargo
AUGUST 5, 2020
The post Developing Drug Products with the Label’s Commercial Value in Mind appeared first on Camargo. Whether you plan to out-license or commercialize your product, getting the label right matters.
Scienmag
MARCH 5, 2021
Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples Credit: MPI f.
Outsourcing Pharma
MAY 13, 2021
The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions. Clinical Development
Scienmag
JULY 26, 2021
Bio Pharma Dive
FEBRUARY 1, 2021
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance
Bio Pharma Dive
APRIL 28, 2021
Far along in testing for a hemophilia treatment, BioMarin is expanding its gene therapy research into diseases of the central nervous system and aims to use some of the institute's technology
Let's personalize your content